HCWB HCW Biologics, Inc.: Kompaniyaning balans qiymati
HCW Biologics Inc. (HCWB) saraton bilan kurashuvchi dori vositalarini ishlab chiqadi, biroq ilmiy tadqiqotlarga e'tibor qaratgani sababli, ayni paytda barqaror daromad oqimiga ega emas. Firma moliyalashtirish yetishmovchiligiga duch kelmoqda va oqsillarni o'rganish uchun o'z rezervlarini sarflamoqda. Biznes organizmning yoshartirishi uchun T-hujayralarni faollashtirish platformasiga tayanadi va ko'rsatkich 0.01 darajasida turibdi. Quyidagi aksiyalar narxining harakati ushbu biofarmatsevtika loyihasining bozor qiymatini aks ettiradi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_Company-Book-Value "HCW Biologics Inc (HCWB): Sof aktivlar qiymati 04.07.2022dan 28.10.2026gacha | 👁️GURU.Markets👁️")
HCW Biologics Inc (HCWB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati HCW Biologics Inc.|HCWB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati HCW Biologics, Inc.|HCWB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari HCW Biologics
Fundamental baholash:HCWB - HCW Biologics
HCW Biologics Inc. (HCWB) laboratoriyalarida tibbiy qoidalarga qat'iy rioya qilinishi moddiy bazaning barqarorligini ta'minlaydi, bu esa kitob kapitalizatsiyasida umumiy aktivlar va majburiyatlar orasidagi farq sifatida aks etadi. Kitob kapitalizatsiyasidagi tebranishlarni tahlil qilish orqali investorlar sof aktiv qiymati bo'yicha bozor konsensusini baholaydilar, bu esa ularga trendning teskari yo'nalishga o'zgarishi paytida risklarni minimallashtirish uchun joriy narxlar dinamikasini foiz stavkalari bilan solishtirish imkonini beradi.
HCW Biologics Inc. raqobatchilari tahlili
ARGX - Kompaniyaning sof aktivlari|BioNTech SE (BNTX) - Balans kapitallashuvi|ABVX (ABIVAX) - Kompaniyaning balans qiymati|Kompaniyaning balans qiymati ADMA Biologics, Inc. ADMA|Sof aktivlar qiymati Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Kiniksa Corp (KNSA)|Balans kapitallashuvi GRFS (Grifols, S.A.)|adaptivebiotech.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Celldex Therapeutics, Inc. (CLDX)|AUPH: Kompaniyaning buxgalteriya qiymati|BCRX (BioCryst Pharmaceuticals Inc) - Kompaniyaning balans qiymati|Vera Corp (VERA) - Kompaniyaning sof aktivlari|DNTH (Dianthus Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Tourmaline Bio Inc (TRML)|Balans kapitallashuvi PGEN|Pharming Corp - Biznesning balans bahosi|NKTR: Kompaniyaning balans qiymati|UPB: Kompaniyaning sof aktivlari|ZBIO (Zenas Biopharma) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Immunome Inc|GOSS (Gossamer Corp) - Kompaniyaning sof aktivlari|Balans kapitallashuvi KALV|Kompaniyaning balans qiymati Septerna Inc SEPN|Buxgalteriya kapitallashuvi pieris.com (PVLA)|SVRA: Balans kapitallashuvi|Kompaniyaning xususiy kapitali Rigel Pharma RIGL|Balans kapitallashuvi AnaptysBio Corp (ANAB)|ATXS - Kompaniyaning buxgalteriya qiymati|ENGN (enGene Holdings Inc.) - Balans kapitallashuvi|Kompaniyaning sof aktivlari rapt.com|Kompaniyaning sof aktivlari JBIO|Kompaniyaning sof aktivlari Aclaris Therapeutics Inc. (ACRS)|Kyverna (KYTX) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Tiziana Life Sciences, Ltd. (TLSA)|Balans kapitallashuvi Cabaletta Bio, Inc. CABA|Kompaniyaning balans qiymati ventyxbio.com VTYX|Balans kapitallashuvi THTX (Theratechnologies)|AVTX: Biznesning balans bahosi|Kompaniyaning balans qiymati ELDN|AGEN (Agenus, Inc) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Climb Bio Inc|Kompaniyaning balans qiymati ZURA|aTyr Pharma - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali adagene.com (ADAG)|IMA (Ikena Oncology) - Balans kapitallashuvi|Biznesning balans qiymati Shattuck Labs Inc STTK|Balans kapitallashuvi EQ (Equillium Bio)|CNTB - Biznesning balans bahosi|IMUX (immunic-therapeutics.com) - Balans kapitallashuvi|ATRA (Atara Bio) - Kompaniyaning sof aktivlari|IFRX: Kompaniyaning balans qiymati|Biznesning balans bahosi X4 Pharmaceuticals, Inc (XFOR)|Adicet Bio (ACET) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati celularity.com (CELU)|Balans kapitallashuvi INMB|Barinthus Biotherapeutics PLC - Biznesning balans bahosi|Kezar Life Sciences, Inc (KZR) - Kompaniyaning balans qiymati|SABS - Buxgalteriya kapitallashuvi|AKTX (Akari Therapeutics) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Enlivex Therapeutics Ltd.|QTTB: Kompaniyaning sof aktivlari|Biznesning balans bahosi GeoVax Labs|Edesa (EDSA) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati iBio Corporation (IBIO)|Carisma Therapeutics Inc. - Balans kapitallashuvi|XTLB - Kompaniyaning sof aktivlari|BOLT: Kompaniyaning sof aktivlari|APVO - Kompaniyaning sof aktivlari|AIM ImmunoTech (AIM) - Balans kapitallashuvi|ADTX (Aditxt, Inc.) - Kompaniyaning balans qiymati|Kompaniyaning balans qiymati GRI Bio, Inc. GRI|Sof aktivlar qiymati xortx.com|Vyome Holdings (HIND) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Revelation Biosciences Inc (REVB)|Balans kapitallashuvi INDP (Indaptus)|BiondVax Pharmaceuticals - Balans kapitallashuvi|Kompaniyaning balans qiymati CalciMedica Corp (CALI)|AFMD: Kompaniyaning buxgalteriya qiymati|ALLK (allakos.com) - Kompaniyaning balans qiymati|HOOKIPA Pharma (HOOK) - Kompaniyaning sof aktivlari|IGMS (IGM Biosciences Inc.) - Balans kapitallashuvi|Balans kapitallashuvi iTeos Pharma (ITOS)|Ocean Biomedical, Inc. (OCEA) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati tcbiopharm.com (TCBP)|Balans kapitallashuvi THRD